title: Renal cancer in von Hippel-Lindau disease and related syndromes.
abstract: Sporadic and hereditary forms of renal cell carcinoma (RCC), von Hippel-Lindau (VHL) disease and the familial paraganglioma syndromes are closely related in terms of their clinical, molecular, and genetic aspects. Most RCCs occur sporadically and the heritable fraction of RCC is estimated to be just 2-4%. An understanding of the molecular genetic basis, the disease-specific and gene-specific biology and the clinical characteristics of these cancer syndromes is of utmost importance for effective genetic diagnosis and appropriate treatment. In addition, such insight will improve our understanding of sporadic RCCs. To date, 10 different heritable RCC syndromes have been described. VHL syndrome is the oldest known hereditary RCC syndrome. Similar to VHL disease, phaeochromocytoma is a major manifestation of the paraganglioma syndromes types 1, 3 and 4 in which RCCs have been reported. These syndromes are therefore regarded as VHL-related disorders and are included in this Review. Multifocal tumours, bilateral occurrence, a young age at diagnosis and/or family history are clinical red flags suggestive of hereditary disease and should trigger referral for genetic and molecular analysis. The identification of an underlying genetic alteration enables gene-specific risk assessment and opens up the possibility of a tailored follow-up strategy and specific surveillance protocols as the basis of effective preventive medicine. The important goals of preventive medicine are to increase the life expectancy of affected patients and to improve their quality of life. The study of seemingly rare hereditary syndromes and their susceptibility genes has consistently revealed clues regarding the aetiology and pathogenesis of these diseases, and can aid diagnosis and the development of therapeutics for patients affected by much more common sporadic counterparts.
authors.affiliation: Department of Gastroenterology, Hepatology, Endocrinology and Infectious Diseases, University Hospital, Hugstetter Strasse 55, D-79106 Freiburg, Germany.
authors.forename: Birke
authors.initials: B
authors.lastname: Bausch
authors.forename: Cordula
authors.initials: C
authors.lastname: Jilg
authors.forename: Sven
authors.initials: S
authors.lastname: Gläsker
authors.forename: Alexander
authors.initials: A
authors.lastname: Vortmeyer
authors.forename: Niklas
authors.initials: N
authors.lastname: Lützen
authors.forename: Alexandra
authors.initials: A
authors.lastname: Anton
authors.forename: Charis
authors.initials: C
authors.lastname: Eng
authors.forename: Hartmut P H
authors.initials: HP
authors.lastname: Neumann
mesh_terms: D042241:Early Diagnosis; D020022:Genetic Predisposition to Disease; D005821:Genetic Techniques; D014943:Global Health; D006801:Humans; D015994:Incidence; D007680:Kidney Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control; D011322:Primary Prevention / Q000379:methods*; D011379:Prognosis; D013577:Syndrome; D006623:von Hippel-Lindau Disease / Q000150:complications / Q000175:diagnosis / Q000235:genetics
references.citation: Q J Med. 1990 Nov;77(283):1151-63
references.pmid: 2274658
references.citation: N Engl J Med. 1979 Sep 13;301(11):592-5
references.pmid: 470981
references.citation: J Med Genet. 2007 Sep;44(9):586-7
references.pmid: 17557926
references.citation: Transplantation. 1997 Dec 27;64(12):1726-9
references.pmid: 9422410
references.citation: Am J Surg Pathol. 2010 Jun;34(6):806-15
references.pmid: 20431476
references.citation: Lancet Oncol. 2010 Apr;11(4):366-72
references.pmid: 20071235
references.citation: Endocr Relat Cancer. 2012 May 03;19(3):283-90
references.pmid: 22351710
references.citation: Am J Med Genet A. 2009 Oct;149A(10):2147-51
references.pmid: 19764026
references.citation: Eur Urol. 2011 Nov;60(5):975-82
references.pmid: 21741160
references.citation: Hum Mutat. 2004 Jan;23(1):40-6
references.pmid: 14695531
references.citation: Acta Radiol. 2011 Jul 1;52(6):680-5
references.pmid: 21525107
references.citation: Nat Genet. 1997 May;16(1):68-73
references.pmid: 9140397
references.citation: J Urol. 2007 Nov;178(5):1883-7
references.pmid: 17868732
references.citation: Cancer Cell. 2002 Apr;1(3):237-46
references.pmid: 12086860
references.citation: Fam Cancer. 2012 Sep;11(3):387-94
references.pmid: 22426863
references.citation: Nature. 1999 May 20;399(6733):271-5
references.pmid: 10353251
references.citation: J Urol. 2007 Jun;177(6):2074-9; discussion 2079-80
references.pmid: 17509289
references.citation: Oncogene. 2004 May 20;23(23):4076-83
references.pmid: 15064708
references.citation: AJR Am J Roentgenol. 1992 Dec;159(6):1229-34
references.pmid: 1442389
references.citation: Cancer Cell. 2002 Aug;2(2):157-64
references.pmid: 12204536
references.citation: Fam Cancer. 2005;4(1):43-7
references.pmid: 15883709
references.citation: Eur J Cancer. 2010 Mar;46(4):765-81
references.pmid: 20116997
references.citation: Cancer Cell. 2005 Jan;7(1):77-85
references.pmid: 15652751
references.citation: Urol Int. 2012;88(1):71-8
references.pmid: 22156657
references.citation: Lancet. 2003 Jun 14;361(9374):2059-67
references.pmid: 12814730
references.citation: JAMA. 2005 Oct 26;294(16):2057-63
references.pmid: 16249420
references.citation: Hum Mutat. 1996;8(4):348-57
references.pmid: 8956040
references.citation: Science. 1993 May 28;260(5112):1317-20
references.pmid: 8493574
references.citation: Hum Genet. 2000 Apr;106(4):425-31
references.pmid: 10830910
references.citation: N Engl J Med. 2002 May 9;346(19):1459-66
references.pmid: 12000816
references.citation: Cancer Cell. 2002 Jun;1(5):459-68
references.pmid: 12124175
references.citation: Int Urol Nephrol. 2008;40(3):615-20
references.pmid: 18074239
references.citation: J Med Genet. 1991 Jul;28(7):443-7
references.pmid: 1895313
references.citation: Science. 2009 Aug 28;325(5944):1139-42
references.pmid: 19628817
references.citation: Am J Hum Genet. 2004 Jan;74(1):153-9
references.pmid: 14685938
references.citation: Am J Hum Genet. 1998 Jun;62(6):1475-83
references.pmid: 9585616
references.citation: Fam Cancer. 2011 Sep;10(3):529-34
references.pmid: 21503747
references.citation: J Med Genet. 1996 Feb;33(2):120-7
references.pmid: 8929948
references.citation: J Med Genet. 2012 Apr;49(4):264-9
references.pmid: 22362873
references.citation: J Urol. 2004 Jul;172(1):63-5
references.pmid: 15201738
references.citation: N Engl J Med. 1996 Sep 19;335(12):865-75
references.pmid: 8778606
references.citation: J Clin Oncol. 2004 Dec 15;22(24):4991-5004
references.pmid: 15611513
references.citation: J Urol. 2010 Jul;184(1):59-63
references.pmid: 20478582
references.citation: Eur J Clin Invest. 2010 May;40(5):433-9
references.pmid: 20534065
references.citation: Lancet. 2007 Dec 22;370(9605):2071-3
references.pmid: 18156012
references.citation: J Urol. 2010 May;183(5):1703-7
references.pmid: 20299060
references.citation: BJU Int. 2011 Nov;108(10):1556-63
references.pmid: 21952069
references.citation: J Urol. 2003 Dec;170(6 Pt 1):2163-72
references.pmid: 14634372
references.citation: Ophthalmology. 2006 Aug;113(8):1418-24
references.pmid: 16769118
references.citation: J Urol. 2001 Mar;165(3):777-81
references.pmid: 11176466
references.citation: Nat Cell Biol. 2007 May;9(5):588-95
references.pmid: 17450132
references.citation: J Urol. 2011 Jun;185(6):2056-60
references.pmid: 21496837
references.citation: Nat Genet. 2002 Dec;32(4):676-80
references.pmid: 12434154
references.citation: N Engl J Med. 2007 Jan 11;356(2):115-24
references.pmid: 17215529
references.citation: BJU Int. 2008 Sep;102(8):940-5
references.pmid: 18485044
references.citation: J Urol. 2003 Nov;170(5):1752-5
references.pmid: 14532769
references.citation: J Urol. 2008 Jul;180(1):89-93; discussion 93
references.pmid: 18485404
references.citation: JAMA. 1999 May 5;281(17):1628-31
references.pmid: 10235157
references.citation: Cancer Cell. 2005 Aug;8(2):143-53
references.pmid: 16098467
references.citation: J Urol. 1998 Oct;160(4):1248-54
references.pmid: 9751329
references.citation: Kidney Int. 2005 May;67(5):2069-82
references.pmid: 15840065
references.citation: Hum Mutat. 2010 Jan;31(1):41-51
references.pmid: 19802898
references.citation: J Urol. 1995 Dec;154(6):2010-4; discussion 2014-5
references.pmid: 7500446
references.citation: Urology. 2007 Sep;70(3):435-9
references.pmid: 17905091
references.citation: Am J Surg Pathol. 2011 Oct;35(10):1578-85
references.pmid: 21934479
references.citation: Lancet. 2008 Aug 9;372(9637):449-56
references.pmid: 18653228
references.citation: Lancet. 1991 May 4;337(8749):1052-4
references.pmid: 1673491
references.citation: Nat Genet. 2002 Apr;30(4):406-10
references.pmid: 11865300
references.citation: Fam Cancer. 2005;4(1):37-42
references.pmid: 15883708
references.citation: N Engl J Med. 2007 May 31;356(22):2271-81
references.pmid: 17538086
references.citation: JAMA. 2004 Aug 25;292(8):943-51
references.pmid: 15328326
references.citation: Nat Genet. 1994 May;7(1):85-90
references.pmid: 7915601
references.citation: Medicine (Baltimore). 1997 Nov;76(6):381-91
references.pmid: 9413424
references.citation: N Engl J Med. 2007 Jan 11;356(2):125-34
references.pmid: 17215530
references.citation: J Urol. 1999 May;161(5):1475-9
references.pmid: 10210376
references.citation: N Engl J Med. 2011 Mar 3;364(9):885-6
references.pmid: 21366490
references.citation: J Urol. 1995 Jan;153(1):22-6
references.pmid: 7966777
references.citation: J Natl Cancer Inst. 2008 Sep 3;100(17):1260-2
references.pmid: 18728283
references.citation: Hematol Oncol Clin North Am. 2011 Aug;25(4):667-86
references.pmid: 21763962
references.citation: J Urol. 2012 Dec;188(6):2063-71
references.pmid: 23083876
references.citation: Nat Rev Cancer. 2002 Sep;2(9):673-82
references.pmid: 12209156
references.citation: Jpn J Clin Oncol. 2006 Jun;36(6):337-43
references.pmid: 16818478
references.citation: Eur Urol. 2013 Apr;63(4):646-52
references.pmid: 23041360
references.citation: J Clin Endocrinol Metab. 2000 May;85(5):1758-64
references.pmid: 10843148
references.citation: N Engl J Med. 2006 Jun 22;354(25):2729-31
references.pmid: 16790714